Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0000950170-25-087025

Director sold 7,000 shares at $4.59 ($32,130)

From the SEC's structured data for this filing

Trades in this filing

Mitchell Stephen Ray · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-13 Sale : show line 1 in the form −7,000 $4.59 $32,130 97,082 D
Open-market sales · 7,000 sh · avg $4.59 · $32,130
Loading xslF345X05/ownership.xml…